Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Prospects for new and effective antimalarial treatments have improved significantly in the past few years. There are more funds, new operational paradigms and actors, and more products in the pipeline. However, the limited novelty of the products currently in clinical development means that more emphasis therefore needs to be placed on the discovery of novel chemical entities to achieve effective, sustainable control. The development and deployment of new products is both lengthy and complex.


Journal article


Bulletin de l'Academie nationale de medecine

Publication Date





1285 - 1292



Humans, Malaria, Sesquiterpenes, Artemisinins, Lactones, Antimalarials, Drug Therapy, Combination, Drug Evaluation, Preclinical, Drug Design, Forecasting, Adult, Child, Research Support as Topic